Unknown

Dataset Information

Depressive symptoms and CSF Alzheimer's disease biomarkers in relation to clinical symptom onset of mild cognitive impairment.


ABSTRACT:

Introduction

We sought to examine whether depressive symptoms and level of Alzheimer's disease (AD) pathology are independently or interactively associated with the risk of progression to mild cognitive impairment (MCI).

Methods

The study included a total of 216 participants from the Biomarkers for Older Controls at Risk for Alzheimer's Disease study, a cohort of individuals who were cognitively normal at baseline (mean age = 57) and followed for more than 20 years (mean = 12.7 years), who had baseline Hamilton Depression Scale (HAM-D) scores and cerebrospinal fluid (CSF) amyloid beta (Aβ)1-42 , t-tau, and p-tau measures available.

Results

Cox regression demonstrated that baseline HAM-D and CSF AD biomarkers were both associated with time to onset of MCI. T

SUBMITTER: Chan CK 

PROVIDER: S-EPMC7513625 | biostudies-literature | 2020

REPOSITORIES: biostudies-literature